Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Mirjana Doknic"'
Autor:
Dragana Miljic, Sandra Pekic, Mirjana Doknic, Marko Stojanovic, Sasa Ilic, Marina Nikolic Djurovic, Zvezdana Jemuovic, Toplica Milojevic, Mihailo Milicevic, Marija Jovanovic, Milica Medic Stojanoska, Bojana Carić, Nevena Radic, Sanja Medenica, Emilija Manojlovic Gacic, Milan Petakov
Publikováno v:
Endocrine Journal, Vol 71, Iss 3, Pp 285-293 (2024)
Pituitary xanthogranulomatomas (XG) are a rare pathological entity caused by accumulation of lipid laden macrophages and reactive granuloma formation usually triggered by cystic fluid leakage or hemorrhage. Our aim was to compare clinical characteris
Externí odkaz:
https://doaj.org/article/997e5d41cc9e4904bf16ba6c3560d120
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 19, p 10313 (2024)
The aim of this review article is to highlight the consequences of COGHD after the end of linear growth on bone mass and body composition and the opposing beneficial effects of continuing GH replacement in the transition period and young adults. The
Externí odkaz:
https://doaj.org/article/664e3b2bfe0b4ead88c93f7f30811f96
Autor:
Mirjana Doknic, Marko Stojanovic, Ivan Soldatovic, Tatjana Milenkovic, Vera Zdravkovic, Maja Jesic, Sladjana Todorovic, Katarina Mitrovic, Rade Vukovic, Dragana Miljic, Dragan Savic, Mihajlo Milicevic, Aleksandar Stanimirovic, Vojislav Bogosavljevic, Sandra Pekic, Emilija Manojlovic-Gacic, Aleksandar Djukic, Danica Grujicic, Milan Petakov
Publikováno v:
Endocrine Connections, Vol 10, Iss 8, Pp 935-946 (2021)
Objective: To analyze metabolic parameters, body composition (BC), and bone mineral density (BMD) in childhood-onset GH deficiency (COGHD) patients during the transition period (TP). Design: Single- center, retrospective study was performed on 170 co
Externí odkaz:
https://doaj.org/article/a55589e0301644d3837585e4d70c98e5
Autor:
Marek Bolanowski, Zaina Adnan, Mirjana Doknic, Mykola Guk, Václav Hána, Irena Ilovayskaya, Darko Kastelan, Tomaz Kocjan, Martin Kužma, Akmaral Nurbekova, Catalina Poiana, Nikolette Szücs, Silvia Vandeva, Roy Gomez, Sorin Paidac, Damien Simoneau, Ilan Shimon
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Acromegaly is a rare condition typically caused by benign pituitary adenomas, resulting in excessive production of growth hormone. Clinical manifestations of acromegaly are diverse, varying from the overgrowth of body tissue to cardiovascular, metabo
Externí odkaz:
https://doaj.org/article/1bca364d9bca4016abd46e5ab897aea3
Autor:
Marko Stojanovic, Zida Wu, Craig E Stiles, Dragana Miljic, Ivan Soldatovic, Sandra Pekic, Mirjana Doknic, Milan Petakov, Vera Popovic, Christian Strasburger, Márta Korbonits
Publikováno v:
Endocrine Connections, Vol 8, Iss 4, Pp 326-337 (2019)
Background: Aryl hydrocarbon receptor-interacting protein (AIP) is evolutionarily conserved and expressed widely throughout the organism. Loss-of-function AIP mutations predispose to young-onset pituitary adenomas. AIP co-localizes with growth hormon
Externí odkaz:
https://doaj.org/article/e57dfafa287449668177691133d77aa5
Autor:
Djurdjevic Sandra Pekic, Marko Stojanovic, Mirjana Doknic, Dragana Miljic, Toplica Milojevic, Mihailo Milicevic, Aleksandar Stanimirovic, Vuk Scepanovic, Gacic Emilija Manojlovic, Sandra Banjalic, Marija Jovanovic, Zvezdana Jemuovic, Djurovic Marina Nikolic, Danica Grujicic, Vera Popovic, Milan Petakov
Publikováno v:
Endocrine Abstracts.
Autor:
Harpal Randeva, Monica Gadelha, Murray Gordon, Mirjana Doknic, Emese Mezősi, Miklos Toth, Cesar Boguszewski, Christine Ferrara-Cook, Alessandra Casagrande, Alan Krasner
Publikováno v:
Endocrine Abstracts.
Autor:
Hiba Masri Iraqi, Ilan Shimon, Ekaterina Pigarova, Annamaria Colao, Lior Baraf, Marina Tsoli, Mirjana Doknic, Silvia Ricci Bitti, Roberta Giordano, Mattia Barbot, Amit Akirov, Przemyslaw Witek, Merav Serebro, Matthias Auer, Miklós Tóth
Central Diabetes Insipidus (CDI) is mainly associated with structural pathologies of the hypothalamic-pituitary area. Etiologies underlying CDI are identified in most patients, however idiopathic CDI is reported in 13-17% of cases after excluding oth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e304426734779ad601686a5ba13f86b6
https://doi.org/10.21203/rs.3.rs-1929792/v1
https://doi.org/10.21203/rs.3.rs-1929792/v1
Autor:
Monica R Gadelha, Murray B Gordon, Mirjana Doknic, Emese Mezősi, Miklós Tóth, Harpal Randeva, Tonya Marmon, Theresa Jochelson, Rosa Luo, Michael Monahan, Ajay Madan, Christine Ferrara-Cook, R Scott Struthers, Alan Krasner
Publikováno v:
The Journal of clinical endocrinology and metabolism.
Context Paltusotine is a once-daily, oral, nonpeptide small-molecule somatostatin receptor type 2 (SST2) agonist in clinical development for treatment of acromegaly. Objective This work aimed to evaluate change in insulin-like growth factor I (IGF-I)
Autor:
Zvezdana Jemuovic, Marina Nikolic Djurovic, Sandra Pekic Djurdjevic, Dragana Miljic, Marko Stojanovic, Mirjana Doknic, Ana Petakov, Milan Petakov
Publikováno v:
Endocrine Abstracts.